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Background:  Healthcare policy for reducing cardiovascular (CV) event burden should be guided by current and generalizable data. The 
objective was to determine the CV event risk in US patients with established atherosclerotic CV disease (ASCVD) and/or diabetes mellitus.
methods:  The MarketScan Research Database was used for this analysis. Inclusion criteria included a valid low-density lipoprotein 
cholesterol (LDL-C) measurement in 2009, age ≥20 years and evidence of CV disease and/or diabetes prior to the LDL-C measurement 
date (i.e. the index date). Both treated (with lipid-lowering therapy) and untreated patients were assigned to mutually-exclusive categories 
in the following order: ACS ≤12 months; MI >12 months; other CHD; ischemic stroke; PAD; and diabetes mellitus. Time to the composite 
endpoint of MI, unstable angina, coronary revascularization, ischemic stroke or CV death (estimated as 60% of all-cause death based on 
published sources) was calculated. Kaplan-Meier plots with log-rank tests were used.
results:  Inclusion criteria were met by 15,772 with ASCVD and 21,218 patients with only diabetes. Median (Q1-Q3) age was 59 (52-64) 
years, median (Q1-Q3) LDL-C was 88 (70-111) mg/dL, and 61% were male. Event rates are reported in the Table.
Kaplan-Meier CV Event Rates
Diabetes (N=5,041) No Diabetes (N=10,731) p-value
Cohort Frequency One-year Event Rate [95% CI] Cohort Frequency
One-year Event Rate [95% 
CI]
ACS 0-12 mo. prior 
to index 7.4% 22.0% [18.5%, 26.1%] 6.7% 18.3%[15.8%, 21.2%] 0.0206
MI >12 mo. prior to 
index 13.9% 14.9%[12.6%, 17.5%] 13.1% 12.7%[11.1%, 14.4%] <0.001
Other CHD 57.4% 7.4%[6.6%, 8.3%] 60.3% 4.2%[3.7%, 4.7%] <0.001
Ischemic Stroke 7.0% 6.4%[4.4%, 9.3%] 8.2% 4.3%[3.2%, 5.8%] 0.1002
PAD 14.3% 5.7%[4.3%, 7.3%] 11.8% 4.2%[3.4%, 5.3%] <0.001
The one-year event rate for diabetics without ASCVD (N=21,218) was 1.5% (95% CI: 1.4%, 1.7%)
ACS, acute coronary syndrome; CHD, coronary heart disease; MI, myocardial infarction; PAD, peripheral arterial disease
Conclusion:  Despite treatment, these data suggest CV event rates continue to remain high in the US for patients with ASCVD. The 
presence of diabetes mellitus is associated with higher event rates in ASCVD.
